A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity

Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

NCT02918279 ·Status: COMPLETED ·Phase: PHASE3

The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients

NCT04839237 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of MK0364 in Obese Patients (0364-014)

NCT00131391 ·Status: TERMINATED ·Phase: PHASE3

First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease

NCT05517564 ·Status: UNKNOWN ·Phase: PHASE1

Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg

NCT03534310 ·Status: COMPLETED ·Phase: NA

Aleniglipron Phase 2 Body Composition Study

NCT07169942 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)

NCT00131430 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus

NCT06174779 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of BGM0504 in Participants With Obesity

NCT06911203 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy Study of S-309309 in Obese Adults

NCT05925114 ·Status: COMPLETED ·Phase: PHASE2

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

NCT00396448 ·Status: TERMINATED ·Phase: PHASE3

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

NCT00375401 ·Status: TERMINATED ·Phase: PHASE3

The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients

NCT04605861 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

NCT07205900 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

NCT07081958 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity

NCT04707313 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

NCT06047548 ·Status: COMPLETED ·Phase: PHASE3

Real-life Evaluation of WEGOVY (Semaglutide) Treatment in Adults With Monogenic Obesity (ObGeSema)

NCT06380426 ·Status: RECRUITING

Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects

NCT00909766 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects

NCT00388609 ·Status: TERMINATED ·Phase: PHASE2

A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity

NCT06259981 ·Status: COMPLETED ·Phase: PHASE2

A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

NCT00483171 ·Status: TERMINATED ·Phase: PHASE3

Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM

NCT05199090 ·Status: TERMINATED ·Phase: PHASE2

Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity

NCT06579092 ·Status: COMPLETED ·Phase: PHASE2

Lifestyle Modification and Liraglutide

NCT02911818 ·Status: COMPLETED ·Phase: PHASE4